How to cite item

Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?

   
@article{HBSN24922,
	author = {Masahiro Ogawa and Tatsuo Kanda and Mitsuhiko Moriyama},
	title = {Are direct-acting antivirals against hepatitis C virus infection not  associated with the recurrence of hepatocellular carcinoma?},
	journal = {Hepatobiliary Surgery and Nutrition},
	volume = {8},
	number = {4},
	year = {2019},
	keywords = {},
	abstract = {Hepatitis C virus (HCV) infection is one of the major causes of end-stage liver disease and hepatocellular carcinoma (HCC). Before the use of direct acting antivirals (DAAs) against HCV, liver transplantation was one of the best ways to achieve long-term survival and a better prognosis in patients with HCV infection and advanced liver fibrosis (1). In the interferon era, it is difficult for HCV infected patients with advanced liver fibrosis to achieve sustained virological response (SVR) because interferon therapy causes severe adverse events and these completely hamper this treatment in these patients.},
	issn = {2304-389X},	url = {https://hbsn.amegroups.org/article/view/24922}
}